Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Moderna Announces Omicron-containing Bivalent Booster Candidate Mrna-1273.214 Demonstrates Superior Antibody Response Against Omicron
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
ABL and Coave Therapeutics Collaborate to Develop Manufacturing Processes and Create Joint Capabilities for Process Development
Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS […]
European Commission Approves Roche’s Tecentriq as Adjuvant Treatment for a Subset of People With Early-stage Non-small Cell Lung Cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) […]
Bayer’s Bluerock Therapeutics Establishes European Site for Cell Therapy Innovation
Bayer AG announced today that BlueRock Therapeutics LP (BlueRock), a clinical stage biopharmaceutical company and […]
Patients to Have Earlier Access to Cutting-edge Treatments on NHS
NHS patients in England will have early access to potentially life-saving and cutting-edge treatments thanks […]
Obesity Linked to Damaging Changes in Failing Hearts
Obesity is linked to changes in the structure and pumping action of the heart before […]
Optibrium Expands UK Head Office With New Facilities on Cambridge Innovation Park
Optibrium™, a developer of software for drug discovery, today announced the expansion of its UK […]
European Commission Approves Roche’s First-in-class Bispecific Antibody Lunsumio for People With Relapsed or Refractory Follicular Lymphoma
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has granted conditional […]
Cancer Vaccine Biotech CimCure Raises € 5 Million in Seed Round Investment Led by Positron Ventures
CimCure, a biotech spin-off of Amsterdam UMC, focusing on the development of a novel vaccine-based […]
Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.
Pfizer Inc. (NYSE: PFE) announced today that it will further strengthen its commitment to United States […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more